Submitted by Anonymous (not verified) on Mon, 09/05/2016 - 22:32
Secretive system for vetting cancer drug use needs an overhaulThe Boston GlobeSpecifically, 86 percent of 125 experts who served on NCCN panels held at least one financial conflict of interest in 2014, according to a new study in the Journal of the American Med
